Is Docgo Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: DCGO) stock is to Strong Buy DCGO stock.
Out of 2 analysts, 1 (50%) are recommending DCGO as a Strong Buy, 1 (50%) are recommending DCGO as a Buy, 0 (0%) are recommending DCGO as a Hold, 0 (0%) are recommending DCGO as a Sell, and 0 (0%) are recommending DCGO as a Strong Sell.
What is DCGO's forecast return on equity (ROE) for 2023-2024?
(NASDAQ: DCGO) forecast ROE is 23.76%, which is considered strong.
What is DCGO's Price Target?
According to 2 Wall Street analysts that have issued a 1 year DCGO price target, the average DCGO price target is $12.50, with the highest DCGO stock price forecast at $14.00 and the lowest DCGO stock price forecast at $11.00.
On average, Wall Street analysts predict that Docgo's share price could reach $12.50 by Apr 21, 2024. The average Docgo stock price prediction forecasts a potential upside of 36.46% from the current DCGO share price of $9.16.
What is DCGO's forecast return on assets (ROA) for 2023-2024?
(NASDAQ: DCGO) forecast ROA is 16.25%, which is higher than the forecast US Medical Care Facilities industry average of 8.06%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.